AbbVie, Abbott Move For JMOL In 2nd AndroGel MDL Bellwether Trial
CHICAGO — AbbVie Inc. and Abbott Laboratories on July 17 moved for judgment as a matter of law in the second AndroGel bellwether trial, arguing that the plaintiff so far has...To view the full article, register now.
Already a subscriber? Click here to view full article